Connecting Genetic Mutations to Health

At a Nevada stop on the Road to 50 States road trip, Martin Schiller, Chairman and CEO at Heligenics, talks to Nigel about the mission and vision for Heligenics and its original connection to the University of Nevada, Los Vegas.

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.


The GigaAssay is a massively parallelized platform for assaying molecular functions of single cells in culture without the need for mechanical separation of the cells.

Heligenics Inc. was formed to implement the GigaAssay to produce saturating mutation/function maps for key genes already established for both inherited disease and cancer diagnostics, or associated with actionable therapies.

The GigaAssay technology was developed at the University of Nevada Las Vegas in the Schiller Laboratory of Applied Bioinformatics. As a massively parallel biological assay that can simultaneously measure how millions of genetic variants or other sequence variables affect the molecular function of cell process, this would take many years if not decades to accomplish using conventional methods. To date, there are no other established assays that assess cell processes and molecular functions in human cells at this kind of scale.